The role of two enzymes (LDH and PHI) and a tumour marker (CEA) in the prognostic evalution of head and neck malignancy

Indian J Otolaryngol Head Neck Surg. 2001 Jan;53(1):76-80. doi: 10.1007/BF02910990.

Abstract

A study of 30 patients with biopsy proven carcinoma of head and neck were taken and serum levels of CEA, LDH and PHI was estimated before treatment and 3 months post treatment. 30 patients were taken as controls for comparison. Pre- and past-treatment levels were statistically compared and the role of surgery, radiotherapy and chemotherapy compared. Variation with metastasis and with smoking was also evaluated.